# Platform Adaptive Embedded Trial for Acute Respiratory Distress Syndrome

> **NCT05658692** · PHASE4 · UNKNOWN · sponsor: **Second Affiliated Hospital, School of Medicine, Zhejiang University** · enrollment: 1000 (estimated)

## Conditions studied

- Acute Respiratory Distress Syndrome

## Interventions

- **DEVICE:** protective ventilation
- **BEHAVIORAL:** prone position ventilation
- **DRUG:** glucocorticoid therapy
- **OTHER:** restrictive fluid resuscitation
- **BIOLOGICAL:** Thymosin Alpha
- **DRUG:** Muscle relaxant therapy
- **OTHER:** Integrated Chinese and Western Medicine Treatment
- **DRUG:** statin therapy
- **COMBINATION_PRODUCT:** anti-infective treatment
- **DEVICE:** Extracorporeal Membrane Oxygenation（ECMO）
- **GENETIC:** stem cell therapy
- **DRUG:** Sedative analgesia/muscle relaxant therapy
- **DRUG:** inotropes therapy
- **DRUG:** Vasoactive drug therapy

## Key facts

- **NCT ID:** NCT05658692
- **Lead sponsor:** Second Affiliated Hospital, School of Medicine, Zhejiang University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-10-01
- **Primary completion:** 2023-10
- **Final completion:** 2023-12
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2022-12-21

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05658692

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05658692, "Platform Adaptive Embedded Trial for Acute Respiratory Distress Syndrome". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05658692. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*